Literature DB >> 9712777

Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region.

Q Mei1, R E Turner, V Sorial, D Klivington, C W Angus, J A Kovacs.   

Abstract

To facilitate studies of Pneumocystis carinii infection in humans, we undertook to better characterize and to express the major surface glycoprotein (MSG) of human P. carinii, an important protein in host-pathogen interactions. Seven MSG genes were cloned from a single isolate by PCR or genomic library screening and were sequenced. The predicted proteins, like rat MSGs, were closely related but unique variants, with a high level of conservation among cysteine residues. A conserved immunodominant region (of approximately 100 amino acids) near the carboxy terminus was expressed at high levels in Escherichia coli and used in Western blot studies. All 49 of the serum samples, which were taken from healthy controls as well as from patients with and without P. carinii pneumonia, were reactive with this peptide by Western blotting, supporting the hypothesis that most adult humans have been infected with P. carinii at some point. This recombinant MSG fragment, which is the first human P. carinii antigen available in large quantities, may be a useful reagent for investigating the epidemiology of P. carinii infection in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712777      PMCID: PMC108515          DOI: 10.1128/IAI.66.9.4268-4273.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Reduced concentrations of IgG antibodies to Pneumocystis carinii in HIV-infected patients during active Pneumocystis carinii infection and the possibility of passive immunisation.

Authors:  S M Burns; J A Read; P L Yap; R P Brettle
Journal:  J Infect       Date:  1990-01       Impact factor: 6.072

2.  Translocation of surface antigen genes to a unique telomeric expression site in Pneumocystis carinii.

Authors:  S M Sunkin; J R Stringer
Journal:  Mol Microbiol       Date:  1996-01       Impact factor: 3.501

3.  Serologic responses to Pneumocystis carinii antigens in health and disease.

Authors:  S L Peglow; A G Smulian; M J Linke; C L Pogue; S Nurre; J Crisler; J Phair; J W Gold; D Armstrong; P D Walzer
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

4.  Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor.

Authors:  R A Ezekowitz; D J Williams; H Koziel; M Y Armstrong; A Warner; F F Richards; R M Rose
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

5.  120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.

Authors:  P E Zimmerman; D R Voelker; F X McCormack; J R Paulsrud; W J Martin
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

6.  Purification and characterization of a major human Pneumocystis carinii surface antigen.

Authors:  B Lundgren; G Y Lipschik; J A Kovacs
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

7.  Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection.

Authors:  D J Fisher; F Gigliotti; M Zauderer; A G Harmsen
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene.

Authors:  J C Edman; U Edman; M Cao; B Lundgren; J A Kovacs; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  Glycoproteins composed of major surface immunodeterminants of Pneumocystis carinii.

Authors:  K Tanabe; S Takasaki; J Watanabe; A Kobata; K Egawa; Y Nakamura
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

10.  Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein.

Authors:  S T Pottratz; J Paulsrud; J S Smith; W J Martin
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more
  22 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  Serodiagnosis of mycoses using recombinant antigens.

Authors:  Natalia Elguezabal; Fernando Lopitz-Otsoa; Ana Laín; Iñigo Fernández de Larrinoa; María Dolores Moragues; José Pontón
Journal:  Mycopathologia       Date:  2005-09       Impact factor: 2.574

3.  Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers.

Authors:  S L Vargas; C A Ponce; F Gigliotti; A V Ulloa; S Prieto; M P Muñoz; W T Hughes
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones.

Authors:  K R Daly; J V Koch; N J Shire; L Levin; P D Walzer
Journal:  Clin Vaccine Immunol       Date:  2006-10

5.  B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection.

Authors:  Sanbao Ruan; Yang Cai; Alistair J Ramsay; David A Welsh; Karen Norris; Judd E Shellito
Journal:  Vaccine       Date:  2016-12-21       Impact factor: 3.641

6.  Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia.

Authors:  Matthew R Gingo; Lorrie Lucht; Kieran R Daly; Kpandja Djawe; Frank J Palella; Alison G Abraham; Jay H Bream; Mallory D Witt; Lawrence A Kingsley; Karen A Norris; Peter D Walzer; Alison Morris
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

7.  Expression of Pneumocystis jirovecii major surface glycoprotein in Saccharomyces cerevisiae.

Authors:  Geetha Kutty; Katherine J England; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

8.  Variation in the major surface glycoprotein genes in Pneumocystis jirovecii.

Authors:  Geetha Kutty; Frank Maldarelli; Guillaume Achaz; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

9.  Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens.

Authors:  K Daly; J Koch; N Respaldiza; C de la Horra; M A Montes-Cano; F J Medrano; J M Varela; E J Calderon; P D Walzer
Journal:  Clin Microbiol Infect       Date:  2009-03-21       Impact factor: 8.067

10.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.